Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Cassava Sciences Stock Soared Today

TheMotleyFool

0 0

Shares of Cassava Sciences (NASDAQ: SAVA) soared 12.6% on Monday. The solid gain came after the company provided a clinical update on several programs.

With Biogen recently winning U.S. Food and Drug Administration (FDA) approval for Aduhelm in treating Alzheimer's disease, investors are keenly focused on any progress with other programs targeting the disease. Cassava's progress report, which came on a day when the overall stock market delivered a strong performance, was enough to serve as a solid catalyst for the biotech stock.

Image source: Getty Images.

Source Fool.com

Like: 0

SAVA

Share